Kang, K <br/><br/>
Thymopoietin pentapeptide (TP-5) improves clinical parameters and lymphocyte subpopulations in atopic dermatitis.  [electronic resource] 

 -  Journal of the American Academy of Dermatology  Mar 1983 
 - 372-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0190-9622 
<br/><br/><label>Standard No.: </label>10.1016/s0190-9622(83)70042-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Dermatitis, Atopic--drug therapy<br/>Double-Blind Method<br/>Hormones--therapeutic use<br/>Humans<br/>Immunoglobulin E--metabolism<br/>Leukocyte Count<br/>Lymphocytes--drug effects<br/>Middle Aged<br/>Peptide Fragments--therapeutic use<br/>Thymopentin<br/>Thymopoietins--therapeutic use<br/>Thymus Hormones--therapeutic use